Patents by Inventor Dale Ian GODFREY

Dale Ian GODFREY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND USES THEREOF
    Publication number: 20230028742
    Abstract: The present disclosure relates generally to compositions for inducing an immunosuppressive phenotype in an antigen presenting cell of the immune system via ligands that activate CD1d signaling. Uses thereof in a therapeutic protocol for treating or preventing conditions associated with aberrant immune system activation, such as autoimmune disease, inflammatory disease, allergy and transplant rejection are detailed.
    Type: Application
    Filed: December 24, 2020
    Publication date: January 26, 2023
    Inventors: Garth CAMERON, Nicholas Anthony GHERARDIN, Catarina Filipa DOS SANTOS SA E ALMEIDA, Dale Ian GODFREY
  • COMPOSITIONS AND USES THEREOF
    Publication number: 20230025334
    Abstract: The present disclosure relates generally to compositions for enhancing an immune response in an antigen presenting cell of the immune system via an inhibitor of CD1 signaling. Uses thereof in a therapeutic protocol for treating or preventing conditions associated with a defective or inadequate immune response, such as cancer and infection, are detailed.
    Type: Application
    Filed: December 24, 2020
    Publication date: January 26, 2023
    Inventors: Garth CAMERON, Nicholas Anthony GHERARDIN, Catarina Filipa DOS SANTOS SA E ALMEIDA, Dale Ian GODFREY
  • METHOD OF INHIBITING OR ACTIVATING GAMMA DELTA T CELLS
    Publication number: 20220273713
    Abstract: The present disclosure relates to methods for inhibiting activation of ?? T cells that express a V?9+ TCR in a subject by administering a BTN2A1 antagonist to a subject as well as methods for inducing or enhancing ?? T cells that express a V?9+ TCR in a subject by administering a BTN2A1 antagonist to a subject. The disclosure additionally relates to BTN2A1 antagonists and BTN2A1 agonists.
    Type: Application
    Filed: June 26, 2020
    Publication date: September 1, 2022
    Applicants: The University of Melbourne, Olivia Newton-John Cancer Research Institute, CSL INNOVATION PTY LTD
    Inventors: Andreas BEHREN, Jonathan CEBON, Marc Rigau CORTAL, Thomas Samuel FULFORD, Dale Ian GODFREY, Andrew HAMMET, Simone OSTROUSKA, Con PANOUSIS, Adam Peter ULDRICH
  • GLYCOPEPTIDE VACCINE
    Publication number: 20220233668
    Abstract: The present invention generally relates to a glycopeptide conjugate compound of Formula (I):, as described herein, compositions comprising the conjugate compound and to the use of such a compound to as a vaccine.
    Type: Application
    Filed: May 8, 2020
    Publication date: July 28, 2022
    Inventors: Dale Ian GODFREY, William Ross HEATH, Lauren Eelise HOLZ, Ian Francis HERMANS, Gavin Frank PAINTER, Regan James ANDERSON, Benjamin Jason COPTON, Shivali Ashwin GULAB